ESC 365 - Can we still use ejection fraction for guiding oncologic therapy?

EACVI Premium Access

Can we still use ejection fraction for guiding oncologic therapy?

Session: Cardiotoxicity in oncology: not only heart failure

Topic: Cardiomyopathies

Speaker: Associate Professor J. Plana (Houston, US)

Event: EuroEcho-Imaging 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Juan Carlos Plana

Baylor College of Medicine, Houston (United States of America)

11 presentations

0 follower

3 more presentations in this session

Which drugs causes cardiotoxicity and how do we diagnose.

Speaker: Professor I. Monte (Catania, IT)

Biomarkers and cardiac imaging for detection of cardiotoxicity: the right balance.

Speaker: Associate Professor C. Cadeddu Dessalvi (Cagliari, IT)

ESC guidelines on cancer therapy and cardiotoxicity: the place of cardiac imaging.

Speaker: Professor J. Zamorano Gomez (Madrid, ES)

Access the full session

Cardiotoxicity in oncology: not only heart failure

Speakers: Associate Professor J. Plana, Professor I. Monte, Associate Professor C. Cadeddu Dessalvi, Professor J. Zamorano Gomez

About the event

EuroEcho-Imaging 2017

6 December - 9 December 2017

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources